IL22 and colitis: In colitis models, oral uptake of these particles decreased the pro-inflammatory cytokines (TNF-α, IL-6, and IL-1), raised the anti-inflammatory cytokines (IL-10 and IL-22), and was shown to be a preventive therapy against colitis-related malignancy [177].